Ensure product development and delivery success. Accelerate speed to market in the life science industry.
Cora has been named in the 2022 Gartner® Magic Quadrant™ for Strategic Portfolio Management. Get complimentary access here
Project Management for Life Sciences
Connect global teams across territories & divisions
Align strategic and operational objectives across your organization no matter where people are in the world
Centralize & manage data in a single platform while fostering innovation
Manage every stage of drug and medical device manufacturing from R&D to market
Shrewder portfolio selection
Auto-select the preferred portfolio based on your criteria and compare alternatives, ensuring your portfolio delivers the maximum return.
Improve portfolio prioritization
Using criteria based on your requirements to score and weight projects, slice-and-dice data to come up with a repeatable, reliable, and robust portfolio scoring mechanism.
Top-down budgeting
Logically split budget across your portfolios. Easily track forecasting from project execution against portfolio budgets to measure performance.
Real-time visibility of your portfolio
A full lifecycle platform providing you with the ability to plan, manage and report on all your R&D, Business Improvement, CapEx, M&A, and OpEx, projects in a centralized location.
Track benefits realization
Manages the whole process of Hoshin Goals, Cost Improvement Programs, or Stretch Targets transparently; avoiding double-counting of benefits and ensure targets are achieved.
Standardized, repeatable processes
Drives process and regulatory compliance and enables repeatable project success; reducing financial, governance, corporate risk, and time to market
Life Science Project Management Practices
Our solutions are intuitive and eliminate the time and frustration around report generation, decision-making, resource allocation, and financial tracking. Enable real-time collaboration, workflow automation, project tracking, and resource management. Time spent on administration will be reduced, freeing you up to focus on what you do best – delivering the highest quality products to the market.
Mapped to your processes
Have you adopted a specific methodology across your organization, but lack a single IT system that enforces a standardized project lifecycle? Our life science software solutions are methodology agnostic, meaning that they are not structured to align to a particular way of thinking, allowing an organization to use any Project Management methodology of their choosing or combine elements from a number of the “traditional” methods.
Sound familiar?
Mario Clarizia outlines the challenges he faced before implementing our solution
“…when the Head of Manufacturing would have asked me what are our top priorities? What are the top projects we’re working on, whether our resources focused on? It could take a couple of weeks to pull that information together.”
Your problems, our solutions
We understand your pains. For over two decades, we’ve provided project portfolio management solutions to life science, medical device and pharmaceutical providers. With each engagement, we’ve learned to surmount the diverse problems encountered by project managers.
The problem:
It’s difficult to decide what projects should be prioritized.
More
We make it easy for you to define and apply your own standard criteria to projects. You can evaluate them based on a range of factors, including strategic impact, using our repeatable, reliable, and robust portfolio-scoring mechanism, and decide which project(s) should be prioritized.
Ready to see how it works?
Our highly trained experts are standing by, ready to demonstrate and answer all of your questions about pricing, implementation, or anything else.
Free pharma guide The future of pharma project management
A free guide to overcoming the challenges facing the pharmaceutical industry in this “new normal” Covid-19 has driven a quest for even greater speed in the pharmaceutical industry and with that has come many challenges. This guidebook looks at how pharma project management has changed during the past 12-18 months and offers insight into how global life sciences companies can adapt to the “new normal”.
Download a copy
